Bülent Karabulut

Prof. Dr. Bülent Karabulut is a prominent figure in the field of medical oncology and the President of the Turkish Medical Oncology Society. He recently gained attention for his insights on the promising results of a clinical trial involving Amivantamab, an antibody treatment for head and neck cancer that showed significant tumor reduction in patients who did not respond to standard therapies.